Most CTL Clones Isolated from Endogenous Responses Are Efficient in Tumor Cell Lysis

<p>CTL clones derived from each patient were classified as “efficient” (greater than 40%), “intermediate” (between 10% and 40%), or “low/no” (less than 10%) in lysis of melanoma cells based on data displayed in <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0010028#pmed-0010028-g002" target="_blank">Figure 2</a>. Each bar represents the portion of total clones from each patient with “efficient,” “intermediate,” or “low/no” melanoma lysis potential.